Ignyta appoints Steven L. Hoerter to board of directors
Mr. Hoerter will serve as an independent director, as well as a member of the nominating and corporate governance committee.
Mr. Hoerter has served as Chief Commercial Officer of Agios Pharmaceuticals, Inc. since February 2016 and has more than 20 years of global pharmaceutical and biotechnology experience, previously having served as executive vice president and chief commercial officer at Clovis Oncology, Inc.
Before joining Clovis in 2011, he was general manager and management center head at Roche for the Sub-Saharan Africa and Indian Ocean Region.
From 2005 to 2010, Mr. Hoerter held a variety of positions at Genentech, Inc., including serving on the senior leadership team for Genentech's BioOncology business as senior director, Pipeline Development and Commercial Operations.
Prior to that, he held commercial roles at Chiron Corporation and Eli Lilly and Company in the U.S., Europe and Africa.
Mr. Hoerter received his B.A. from Bucknell University, MBA from Tilburg University and M.S. in management from Purdue University. ■
LATEST MOVES FROM California
- Peregrine Pharmaceuticals appoints Mark R. Bamforth to boards
- Endologix appoints John Onopchenko as COO
- Depomed appoints Santosh J. Vetticaden as CSO
- Wells Fargo names Michael Roemer as chief compliance officer
- ARMO BioSciences appoints Joseph Leveque as CMO
More inside POST
Fonterra net profit $545.86 million Earnings